Concepedia

Teresa E. Williams

TE

Statistics

Publications

4

Citations

122

H-Index

4

Active since

2014

Affiliations

Novartis (United States)(Current)

Teresa E. Williams is an author at Novartis (United States) specializing in pharmacology, drug discovery, and pharmacy.

Publications per year

2014–2016

4

Publications

4

Discovery of RAF265: A Potent mut-B-RAF Inhibitor for the Treatment of Metastatic Melanoma

Teresa E. Williams, Sharadha Subramanian, Joelle Verhagen et al. · ACS Medicinal Chemistry Letters · 2015 · 54 citations · Full text

, , +17

Design, Structure–Activity Relationship, and in Vivo Characterization of the Development Candidate NVP-HSP990

Christopher M. McBride, Barry H. Levine, Yi Xia et al. · Journal of Medicinal Chemistry · 2014 · 28 citations · Full text

, , +16

Discovery of imidazo[1,2-a]-pyridine inhibitors of pan-PI3 kinases that are efficacious in a mouse xenograft model

Wooseok Han, Daniel L. Menezes, Yongjin Xu et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 27 citations · Full text

, , +9

Design and Synthesis of Orally Bioavailable Benzimidazole Reverse Amides as Pan RAF Kinase Inhibitors

Sharadha Subramanian, Abran Costales, Teresa E. Williams et al. · ACS Medicinal Chemistry Letters · 2014 · 13 citations · Full text

, , +15

1–4 of 4